ALETHEIA THERAPEUTICS
Aletheia Therapeutics provides oncology therapeutics based in Fort Collins, Colorado. It engages in developing and commercializing precision cancer therapies by simultaneously targeting two or more of the following biological targets depending on the make-up of a patients' cancer: DNA repair, T-cell activation, metabolic dysfunction, angiogenesis, apoptosis or inflammation.
ALETHEIA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Oncology Therapeutics
Founded:
2018-01-01
Address:
Fort Collins, Colorado, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
165.01 K USD
Similar Organizations
ARase Therapeutics
Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
More informations about "Aletheia Therapeutics"
Aletheia Therapeutics 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Aletheia Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Aletheia Therapeutics - Products, Competitors, Financials, …
About Aletheia Therapeutics Aletheia Therapeutics is a clinical-stage oncology therapeutics company focused on developing approaches for cancer treatment. The company is engaged …See details»
ALETHEIA THERAPEUTICS, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALETHEIA THERAPEUTICS, LLC of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
Alethia Biotherapeutics
AB-16B5 – inhibition of EMT Alethia is developing an inhibitor of EMT for the treatment of invasive carcinomas. AB-16B5 is a humanized IgG2 antibody against an EMT-inducing form of …See details»
Aletheia Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Aletheia Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Aletheia Therapeutics - Michael Sibrava NCC LMHC
Michael Sibrava, NCC, LMHC he/him Michael Sibrava brings over 20 years of experience working in community mental health settings, private practice, group and classroom settings. His experiences working with a wide range of people …See details»
Aletheia Therapeutics - CipherBio
Explore Aletheia Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Aletheia Therapeutics - Funding, Financials, Valuation & Investors
Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer.See details»
Immune Therapeutics Announces Plan to Acquire Aletheia …
ORLANDO, Fla., Dec. 16, 2019 — via OTC PR WIRE — Immune Therapeutics, Inc. (OTCQB: IMUN) (“Immune”, “IMUN” or the “Company”) and Aletheia Therapeutics Corp. (“Aletheia”), a …See details»
Alethia Biotherapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Alethia Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Aletheia BioTherapeutics - Crunchbase Company Profile & Funding
Aletheia BioTherapeutics is a healthcare organization.See details»
Aletheia Therapeutics, Pllc - Products, Competitors, Financials ...
Aletheia Therapeutics, Pllc is a company founded in 2008. Use the CB Insights Platform to explore Aletheia Therapeutics, Pllc's full profile.See details»
Alethia Biotherapeutics Inc. | BDC.ca
Alethia is developing innovative therapeutic approaches in areas of unmet medical needs, capitalizing on its capacity to identify and validate disease-specific targets for the development …See details»
Home | Aletheia
Aletheia's neuroenergetic gene therapies address impaired bioenergetics, which are the common denominator across the entire clinical spectrum of neurodegenerative disease.See details»
Aletheia Therapeutics - Crunchbase
Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer.See details»
Aletheia Therapeutics D $21M in equity, sold $165.01K, 4
$21M in equity, sold $165.01K, 4 investors, D SEC filing by Aletheia Therapeutics on 22 Apr 19, 12:00amSee details»
Immune Therapeutics Acquires Aletheia to Develop Precision …
Dec 17, 2019 NEW YORK – Immune Therapeutics announced on Monday that it plans to acquire development-stage oncology company Aletheia Therapeutics, and the combined entity …See details»
Immune Therapeutics acquires Aletheia Therapeutics - 2019-12-16 ...
Aletheia Therapeutics Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer.See details»
Beam Therapeutics Announces Positive Initial Data for BEAM-302 …
CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base …See details»